PeninÂsula is a bioÂpharÂmaÂ...
PeninÂsula is a bioÂpharÂmaÂceuÂtiÂcal comÂpany focused on the develÂopÂment and comÂmerÂcialÂizaÂtion of antibiÂotics to treat life-â€‹â€‹threatening infecÂtions. The Companyâ€™s misÂsion is to develop optiÂmal anti-â€‹â€‹infective therÂaÂpies that offer improved effiÂcacy, dosÂing and safety charÂacÂterÂisÂtics over existÂing therÂaÂpies. In addiÂtion to DBL Investors, investors include Canaan PartÂners and Domain Associates.
PeninÂsula was acquired by JohnÂson & JohnÂson on June 30th, 2005.
Funding and Financing Rounds
Impact Reports & Metrics
1751 Harbor Bay Parkway
Alameda, California 94502